XML 63 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Summary of Categorization of Assets and Liabilities Measured at Fair Value The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the years ended December 31, 2020 and 2019, there were no transfers between Levels 2 and 3.
    
December 31, 2020
 
    
Total
    
Level 1
    
Level 2
    
Level 3
 
Assets:
                                   
Recurring fair value measurements:
                                   
Cash equivalents
   $ 660      $ 660      $ —        $ —    
Securities owned, at fair value
                                   
ETFs
     24,165        24,165        —          —    
Pass-through GSEs
     8,613        —          8,613        —    
Corporate bonds
     2,117        —          2,117        —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 35,555      $ 24,825     
$
 
10,730      $ —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Non-recurring
fair value measurements:
                                   
AdvisorEngine Inc. (“AdvisorEngine”) – Financial interests
(1)
   $ —        $ —        $ —        $ —    
Thesys Group, Inc. (“Thesys”) – Series Y Preferred Stock
(1)
     —          —          —          —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ —        $ —        $ —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
                                   
Recurring fair value measurements:
                                   
Deferred consideration (Note 12)
   $ 230,137      $ —        $ —        $ 230,137  
    
 
 
    
 
 
    
 
 
    
 
 
 
Non-recurring
fair value measurements:
                                   
Convertible notes
(2)
   $ 170,191      $ —        $ 170,191      $ —    
    
 
 
    
 
 
    
 
 
    
 
 
 
 
(1)
The fair value of the AdvisorEngine financial interests of $9,592 was determined on May 4, 2020, the date in which these financial interests were sold (Note 8). Thesys was written down to zero on September 30, 2020 (Note 10).
 
(2)
Fair value of $145,847 and $24,344 determined on June 16, 2020 and August 13, 2020, respectively (Note 14).
 
    
December 31, 2019
 
    
Total
    
Level 1
    
Level 2
    
Level 3
 
Assets:
                                   
Recurring fair value measurements:
                                   
Cash equivalents
   $ 317      $ 317      $ —        $ —    
Securities owned, at fair value
                                   
ETFs
     17,319        17,319        —          —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 17,636      $ 17,636      $ —        $ —    
    
 
 
    
 
 
    
 
 
    
 
 
 
                                     
Non-recurring
fair value measurements:
                                   
AdvisorEngine Inc. – Financial interests
(1)
   $ 28,172        —          —        $ 28,172  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
                                   
Recurring fair value measurements:
                                   
Deferred consideration (Note 12)
   $ 173,024      $ —        $ —        $ 173,024  
Securities sold, but not yet purchased
     582        582        —          —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 173,606      $ 582      $ —        $ 173,024  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
(1)
Fair value determined on December 31, 2019 (Note 8).
Summary of Reconciliation of Recurring Fair Value Measurements
The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3:
 
    
Years Ended
December 31,
 
    
2020
    
2019
 
Deferred consideration (Note 12)
                 
Beginning balance
   $ 173,024      $ 161,540  
Net realized losses
(1)
     16,811        13,226  
Net unrealized losses
 
(2)
     56,821        11,293  
Settlements
     (16,519      (13,035
    
 
 
    
 
 
 
Ending balance
   $ 230,137      $ 173,024  
    
 
 
    
 
 
 
 
 
(1)
Recorded as contractual gold payments expense on the Company’s Consolidated Statements of Operations.
 
(2)
Recorded as loss on revaluation of deferred consideration – gold payments on the Company’s Consolidated Statements of Operations.